GlaxoSmithKline Gets FDA Approval for Cervical Cancer Vaccine in Girls and Young Women
Links shared publicly online about this topic
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine
drugs.com — “Cervarix (Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant) is used for prevention of cervical cancer. Includes Cervarix side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 16, 2009 at 10:45 pm By:
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine - http://bit.ly/2Y6rH0
FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine | Reuters
reuters.com — “PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX [Human papillomavirus bivalent (types” View full resource at reuters.com
Most Recently Shared on October 16, 2009 at 4:16 pm By:
Skin & Allergy News Health News
RT @Apfeiffer: RT @cancercures: FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine http://bit.ly/3PBG9D
FDA panel backs Glaxo cervical cancer vaccine | Reuters
reuters.com — “GAITHERSBURG, Maryland (Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday. The endorsement” View full resource at reuters.com
Most Recently Shared on September 9, 2009 at 7:01 pm By:
Physician Assistants Health News Feed
FDA panel backs Glaxo cervical cancer vaccine: http://www.reuters.com/article/healthNews/idUSTRE5885AF20090909
FDA panel backs Glaxo cervical cancer vaccine | Reuters
reuters.com — “GAITHERSBURG, Maryland (Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday. The endorsement” View full resource at reuters.com
Most Recently Shared on September 9, 2009 at 9:05 pm By:
Big news for Glaxo: ODAC backs approval of Cervarix for females aged 10 to 25. http://tiny.cc/mopeE
FDA backs new cervical cancer vaccine Cervarix - Sexual health- msnbc.com
msnbc.msn.com — “Federal health officials favor approving GlaxoSmithKline's long-delayed vaccine Cervarix to prevent the leading cause of cervical cancer in U.S. women.” View full resource at msnbc.msn.com
Most Recently Shared on September 9, 2009 at 6:42 pm By:
msnbc.com - Health Health News
FDA backs new cervical cancer vaccine Cervarix http://bit.ly/VTzE3
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Skin & Allergy News
The leading independent newspaper for medical, surgical, and aesthetic dermatology.
-
Physician Assistants
- Physician Assistants (P.A.) are licensed health professionals who practice medicine with the supervision of a physician
Advertisement
